Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.56 USD | +0.56% | +2.30% | +562.94% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Valerie Jansen
CTO | Chief Tech/Sci/R&D Officer | 46 | - |
David Dornan
CTO | Chief Tech/Sci/R&D Officer | 46 | 22-03-13 |
Candice Masse
IRC | Investor Relations Contact | - | - |
Robert Yang
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Darcy Mootz
BRD | Director/Board Member | - | 01-17 |
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,691,171 | 51,590,201 ( 94.33 %) | 52,909 ( 0.0967 %) | 94.33 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+562.94% | 195M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- ELEV Stock
- Company Elevation Oncology, Inc.